PER 3.57% 8.7¢ percheron therapeutics limited

For General Information, page-2752

  1. 720 Posts.
    lightbulb Created with Sketch. 210
    I seriously think now you’re just an out and out prevaricator.

    NEU’s pipeline drug NNZ-2591 has 4 FDA ODD’s for Phelan-McDirmid, Angelman, Pitt Hopkins, and Prader-Willi Syndromes. All in Phase 2 trials.

    30 secs of research on their website under “Pipeline” extracted that.

    Is there any bottom to the depths you will go to fill this forum with your propaganda?


 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.